Leading Australia towards the elimination of viral hepatitis

Similar documents
The Silent Disease Inquiry into Hepatitis C in Australia

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

Re Joint Committee on Law Enforcement Inquiry into crystal methamphetamine (ice)

Needle and Syringe Programs - 17 October 2013

>Hepatitis NSW will continue to

Hepatitis C Strategy. About us. What is hepatitis C?

Victorian AIDS Council Gay Men s Health Centre

Australian Injecting and Illicit Drug Users League. Policy Position Paper 8 Retractable Syringes

Carers Australia Strategic Plan

Promoting hepatitis B vaccination

A voice for positive change in NHS Wales

Bobby Goldsmith Foundation Strategic Plan

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Viral Hepatitis. WHO Regional Office for Europe July 2013

Version for the Silent Procedure 29 April Agenda item January Hepatitis

A Framework for Optimal Cancer Care Pathways in Practice

HIV VACCINE TRIALS: LEGAL AND ETHICAL ISSUES, SOCIAL CONSEQUENCES

The Silent Disease. Inquiry into Hepatitis C in Australia. House of Representatives Standing Committee on Health

Part 1: Introduction & Overview

Blood Borne Viruses (BBV) & What You Need To Know

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

Health Task Force Workplan

ALCOHOL, TOBACCO & OTHER DRUGS COUNCIL TAS INC.

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

POSITION PAPER - THE MENTAL HEALTH PEER WORKFORCE

National Principles for Child Safe Organisations

What do we need to better understand the needs of mobile and migrant populations in Australia? Is a HIV national response achievable?

Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections

Hepatitis C in Australia

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background

Michael Levy Australian National University

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson

Prevention and control of hepatitis B and C in the European Region of WHO

Ending HIV and Australia s success story in PrEP implementation Dr Heather-Marie Schmidt

Challenges and solutions for. life span. June 2011

Mental Health Matters

The Federal Initiative To Address HIV/AIDS in Canada. Canada s Domestic Response to HIV/AIDS

Submission to the National Centre of Excellence to Reduce Violence against Women and their Children

Health Department Role: Eliminating HBV and HCV

Improving Radiotherapy in NSW: answering the tough questions

Hepatitis C capacity strengthening program with Aboriginal Medical Services in regional Australia

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017

Greater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts

The information provided should be used as a guide only and is not a substitute for medical advice.

Hepatitis C What is it? Should I get tested?

ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY

15571/17 YML/ik 1 DG C 1

Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report

Address to Palliative Care Australia Albury, NSW 25 May 2016

Mount Gambier & District Suicide Prevention Network

Hepatitis C in Canada The Stats

Consumer Consultant. PTBA (ichris) Community Mental Health. Owner Angela Micheletto

PROMOTING POSITIVE CHANGE

Submission to Parliamentary Joint Committee on Law Enforcement Inquiry into Crystal Methamphetamine (Ice)

Public Health Association of Australia submission on the commercial supply of Dengvaxia, an attenuated genetically modified dengue vaccine

Working for Health, Justice and Partnership

Action plan for the health sector response to viral hepatitis in the WHO European Region


Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Get Hip to Hep: Partnerships for Prevention

IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP)

Consumer and Community Participation Policy

Training of Peer Educator Ujenzi

Patient and Carer Network. Work Plan

We listen. We care. We support.

Our footprints: a traveller s guide to the COAG implementation process in Western Australia

Breaking the chain of transmission: Nurses' role in preventing STI's

AUSTRALIAN GREEK WELFARE SOCIETY FALLS PREVENTION RESOURCE KIT FOR GREEK COMMUNITY GROUPS IN AUSTRALIA

RESEARCH BUSINESS DEVELOPMENT MANAGER OVARIAN CANCER AUSTRALIA

Position Description: Peer Navigator

Commission on the Status of Women (CSW62) Challenges and opportunities in achieving gender equality and the empowerment of rural women and girls

AIDS Foundation of Chicago Strategic Vision

Curing Hepatitis C in the Ryan White HIV/AIDS Program

aids in asia and the pacific

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I.

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

strategic plan strong teeth strong body strong mind Developed in partnership with Rotary Clubs of Perth and Heirisson

1. Respond to social and political agendas relating to young people and the youth services sector

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention

High Level Across Sector Support to Implement the Three Plans South Australian Aboriginal Chronic Disease Consortium Goal Vision

World Hepatitis Alliance Strategic Plan 2015

Request for meeting re prevention of ill-health - priorities for 2014 Election platforms

National Cross Cultural Dementia Network (NCCDN) A Knowledge Network of value

Youth Democracy Coordinator- Midlands

Fighting Flu. Vaccinating healthcare professionals

IMPLEMENTING THE WHO GLOBAL DEMENTIA ACTION PLAN. Glenn Rees, Chair Alzheimer s Disease International (ADI)

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Community Support Worker - Macarthur Accommodation and Access Program (MAAP)

NHS Youth Forum Coordinator

INVOLVING YOU. Personal and Public Involvement Strategy

Consumer Participation Strategy

Exploring the risks of liver cancer after successful treatment for hepatitis C virus

SUPPORTING PEOPLE LIVING WITH BPD FIGHTING STIGMA AND TAKING ACTION

VCE Health and Human Development

Shiatsu Therapy Association of Australia Inc. SHIATSU THERAPY CODE OF PRACTICE

TREATMENT ORGANISER HORMONE THERAPY FOR PROSTATE CANCER

Global Patient Survey. Country-Specific Report China

ENDING THE EPIDEMICS: A NATIONAL, STATE, AND CITY APPROACH

Viral Hepatitis B and C in North African Countries

Transcription:

Leading Australia towards the elimination of viral hepatitis Australian Federal Election 2016

About Hepatitis Australia Our vision is an end to hepatitis B and hepatitis C in Australia. Our mission is to lead an effective national community response to hepatitis B and hepatitis C in Australia. Our members are the eight state and territory hepatitis organisations: Hepatitis ACT; Hepatitis NSW; Hepatitis Queensland; Hepatitis SA; Hepatitis Victoria; Hepatitis WA; Northern Territory AIDS and Hepatitis Council and, Tasmanian Council on AIDS, Hepatitis and Related Diseases. Contact: Helen Tyrrell - Chief Executive Officer PO Box 716 Woden, ACT, 2606 02 6232 4257 admin@hepatitisaustralia.com www.hepatitisaustralia.com May 2016 Page 2 of 6

Leading Australia towards the elimination of viral hepatitis Australian Federal Election 2016 Introduction As the peak community hepatitis organisation, Hepatitis Australia believes there are three areas for an incoming Government to focus on in relation to viral hepatitis. These include sustaining an effective partnership approach, reducing stigma by speaking out, and bringing attention to the prevention and management of viral hepatitis in Australia s prisons. Australia has been a world leader in responding to the major blood-borne viruses, including hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). Recently, Hepatitis Australia played a pivotal role in ensuring publicly-funded access to new generation medicines for the treatment of HCV; Australia s first step towards eliminating viral hepatitis. The public funding of new direct-acting antiviral medicines through the Pharmaceutical Benefits Scheme (PBS) has put Australia back in the global spotlight as a leader in access to these new medicines for all people living with hepatitis C. This has set us on the path to eliminating viral hepatitis. We need to stay on this path, but there is much more to do. Half-a-million Australians are living with either HBV or HCV as a chronic infection. The impact of chronic conditions such as viral hepatitis extends beyond the individual to their families and friends, and limits the capacity of people to participate fully in the community. Hepatitis Australia believes people living with viral hepatitis, as well as their family and friends are interested in what a future Australian Government will do to support them, and how it will sustain the Australian response to viral hepatitis. The following information is provided to draw attention to these key areas. It asks how the elected Australian Government will respond to viral hepatitis during the next term of Government. Hepatitis Australia asks that in the lead up to the 2016 Federal Election, each of the political parties: 1. State their commitment to sustaining and supporting the national partnership approach to HBV and HCV, as well as other blood borne viruses. 2. Commit to making public statements on World Hepatitis Day (28 July) highlighting the national response to viral hepatitis, supporting the WHO campaign, and assisting to break down stigma. 3. Commit to raising the issue of hepatitis C in prisons, and the establishment of national standards in prison health delivery, including prevention, management and treatment of viral hepatitis as part of the Council of Australian Governments (COAG) Health Council process. Page 3 of 6

1. The partnership approach to blood-borne viruses Background Over four decades ago, Australia led the world in recognising that governments, clinicians, researchers and most importantly, the affected community, had to work in an effective partnership to tackle the public health threat of HIV. The success of that partnership approach is now enshrined in our suite of National Strategies and listed as a guiding principle which underpins Australia s response to all blood-borne viruses, including HBV and HCV. This highly successful partnership approach has been under threat in recent years due to changes to the federal funding environment. While that threat has dissipated to some extent, it is imperative that the national partnership approach to blood-borne viruses is nurtured over the life of the next Federal Government. The Hepatitis Australia Position In line with the National Strategies, Hepatitis Australia believes that the next Australian Government must commit to leadership of an effective national partnership approach in the response to blood-borne viruses, which includes the following measures: consultation with all community partners including Hepatitis Australia respectful and meaningful dialogue between all parties facilitation of cooperative efforts across all aspects of the response action and resources to achieve the goals of the National Strategies. The 2016 Federal Election is an opportune time for all political parties to: State their commitment to sustaining and supporting the national partnership approach to HBV and HCV as well as other blood-borne viruses. Page 4 of 6

2. A public voice against hepatitis-related stigma. Background Many people with HCV continue to experience stigma and discrimination in their daily life, limiting their relationships, access to healthcare and employment. World Hepatitis Day is one of only a handful of disease-specific world health days endorsed by the World Health Organization. It provides a key opportunity for the Australian Government to highlight viral hepatitis, educate the public, and help to reduce stigma and discrimination by framing viral hepatitis as a health condition affecting ordinary Australians that can be prevented, managed and treated. Despite being invited to participate, each Health Minister and Australian Government over the last five years has not issued any public statement for World Hepatitis Day, yet in contrast, Ministerial media releases and/or public statements for World AIDS Day have been the norm. The Hepatitis Australia Position It is vital that the elected Australian Government demonstrates support for people living with viral hepatitis by speaking out on key occasions such as World Hepatitis Day. As a minimum, this will support the Australian response to: create greater public awareness about viral hepatitis challenge the stigma faced by people living with HBV and HCV strengthen the momentum towards elimination of viral hepatitis. The 2016 Federal Election is an opportune time for all political parties to: Commit to making public statements on World Hepatitis Day (28 July), highlighting and supporting the national response to viral hepatitis and assisting to break down stigma. Page 5 of 6

3. The hepatitis crisis in Australian prisons Background Current prison settings provide a high-risk environment for the transmission of HBV and HCV. Many people in prison have contracted HBV or HCV prior to entering prison and in some cases are unaware of their infection. The sharing of unsterile injecting equipment, barbering tools, unsafe tattooing and unprotected sex all contribute to the spread of blood-borne viruses within prisons in every jurisdiction. In 2015, Australia s response to HCV in prisons was in the spotlight as part of the Parliamentary Inquiry into Hepatitis C in Australia. A special sitting of the House of Representatives Committee on Health was dedicated to this subject. This enabled experts and organisations such as Hepatitis Australia to voice their concerns about Australia s poor response to HCV and other blood-borne viruses in prisons. The report from the Committee on Health, The Silent Disease: Inquiry into Hepatitis C in Australia included several recommendations calling on the Australian Government and the State and Territory Governments to work together to address blood-borne viruses in prisons. To date, no Government response to the Parliamentary report has been issued. The Hepatitis Australia Position Attempts to introduce effective prevention strategies in prisons have largely failed. Misconceptions about the risk to prison staff, ill-informed opposition by trade union bodies and lack of sustained political support for the needed changes have prevailed, despite the evidence. There is no nationally consistent approach to the prevention, management and treatment of HBV or HCV in Australia s prisons. Preventing and treating viral hepatitis in the prison environment will have benefits beyond the prison setting, as it can lead to greater awareness and less likelihood of further transmissions in the community. It is important that the Australian Government takes a lead role in establishing an effective, coordinated national response to viral hepatitis in prisons. Such action should focus on: establishing a national coordinated approach to prison health delivery, including prevention, management and treatment of viral hepatitis the development of a minimum national data set to enable the monitoring of viral hepatitis in prisons. The 2016 Federal Election is an opportune time for all political parties to: Commit to raising the issue of HCV in prisons, and the establishment of national standards in prison health delivery, including prevention, management and treatment of viral hepatitis as part of the Council of Australian Governments (COAG) Health Council process. Page 6 of 6